Fosamprenavir
CAS 226700-79-4
In Stock
Fosamprenavir
Cat. No. STUB-API-FOSAMPRENAVIRCAS 226700-79-4In Stock
Technical Data
Cat. No.STUB-API-FOSAMPRENAVIR
CAS226700-79-4
Mol. FormulaC25H36N3O9PS
Mol. Weight585.616 g/mol
IUPAC[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate
SMILESCC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
InChIInChI=1S/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1
InChI KeyMLBVMOWEQCZNCC-OEMFJLHTSA-N
Purity—
Description
Overview
Fosamprenavir is a drug for the treatment of HIV infections. It is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir. The FDA approved it October 20, 2003, while the EMA approved it on July 12, 2004
Anant Labs manufacture and furnish high quality Fosamprenavir impurities for global markets. Our Fosamprenavir EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Fosamprenavir226700-79-4FOS-APVGW433908fos-amprenavirGW-433908VX 175GW 433908[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamateWOU1621EEG
